WeDaita
Research Digest
AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.
Scored for relevance by WeDaita AI · Updated weekly · Not editorial contentComputational and medicinal chemistry advances, approved drugs, and clinical pipeline entries across the full drug design lifecycle.
- Literature — AI-driven molecular generation, virtual screening, ADMET prediction, and structure-based design from PubMed, arXiv, and Semantic Scholar
- FDA Approval — Recently approved small-molecule drugs (NDA approvals) sourced from openFDA
- Clinical Compound — Phase I–III candidates from ChEMBL — molecules in active clinical development not yet approved
- Disclosure — New molecular series and compound profiles curated by Drug Hunter
- Patent — Drug Hunter Patent Gazette roundups with expert annotations on assignees, targets, and key novelty claims
- Industry News — Company announcements, funding rounds, and biotech media coverage
Industry News
Earlier Toxicity Insight Through Proteomic Profiling
Industry News
Selective oestrogen receptor degrader class grows with new cancer approval
Industry News
Lessons from Recently Approved Oral Small Molecules: Dose Regimens, PK, and Safety
Full access requires a free account
Sign in to browse 3 curated items — papers, FDA approvals, clinical compounds, and disclosures.
Sign in for full access